Several popular drugs, such as amoxicillin and penicillin, remain in short supply, and two high-ranking Republican lawmakers want to know why. Rep. James Comer, R-Ky., chair of the House Committee on Oversight and Accountability, and Rep. Lisa McClain, R-Mich., chair of the Subcommittee on Health Care and Financial, demanded answers in a letter to FDA Commissioner Dr. Robert Califf.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.